Tag: COVID-19
Pelican Rotoflex develops automatic machine for making N95 masks
Inspired by the strong desire to contribute to society in fighting against the corona pandemic, Team Pelican has developed a fully automatic machine for...
DST initiates Covid-19 India National Supermodel for monitoring infection transmission
The Department of Science and Technology (DST) has initiated a Covid -19 Indian National Supermodel to help monitor the future transmission of infection, thus...
WHO and Costa Rica launch landmark Covid-19 technology access pool
Thirty countries and multiple international partners and institutions have signed up to support the Covid-19 Technology Access Pool (C-TAP), an initiative aimed at making...
Roche initiates phase III clinical trial of Actemra, RoActemra and remdesivir
Roche announced the initiation of a global phase III, randomized, double-blind, multicenter study (REMDACTA) to evaluate the safety and efficacy of Actemra, RoActemra, and...
Glenmark to commence new Phase 3 clinical trial on a combination...
Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, has announced a new randomized, open-label study to test the combined efficacy of two antiviral drugs...
Sun Pharma gets approval for Nafamostat trials in Covid-19 patients
Sun Pharmaceutical has recently announced that it has received approval from the Drugs Controller General of India (DCGI) to initiate a clinical trial with...
CCMB researchers culture novel coronavirus
The Centre for Cellular and Molecular Biology (CCMB) has established stable cultures of coronavirus (SARS-CoV-2) from patients’ samples. Virologists at CCMB have isolated infectious...
DST sets up taskforce for mapping of technologies by startups on...
The Department of Science and Technology (DST) is coordinating an effort to upscale appropriate technologies and manufacturing available in India. The purpose is to...
Science and Technology in finding solutions to combat Covid-19
Vinod Paul, member NITI Aayog and K Vijay Raghavan, principal scientific adviser to the Government of India, summarized activities on Covid-19 related to Science...
GSK to produce 1 billion doses of vaccine adjuvant in 2021
GSK confirmed its intention to manufacture 1 billion doses of its pandemic vaccine adjuvant system, in 2021, to support the development of multiple adjuvanted...